Gracell Biotechnologies Inc ADR (GRCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRCL | ARVN | RGNX | ||
| Company | Gracell Biotechnologies Inc ADR | Arvinas Inc | Regenxbio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.26 | 12.29 | 15.13 | ||
| High | 10.28 | 12.40 | 15.62 | ||
| Low | 10.17 | 12.05 | 14.55 | ||
| Latest | 10.25 | 12.07 | 14.59 | ||
| Change | +0.01 | -0.11 | -0.41 | ||
| % Change | +0.05% | -0.90% | -2.73% | ||
| Volume | 6,417,100 | 485,200 | 450,900 | ||
| 20-Day Average Volume | 1,332,340 | 813,800 | 724,330 | ||
| Previous Close | 10.25 | 12.18 | 15.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.21 | 11.98 | 14.13 | ||
| 20-Day Raw Stochastic | 53.16% | 49.65% | 61.09% | ||
| 20-Day Relative Strength | 72.75 | 53.17 | 56.84 | ||
| Weighted Alpha | +228.20 | +31.32 | +86.20 | ||
| Today's Opinion | 100% Buy | 96% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 96% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.87% since 02/13/24 | +5.23% since 01/02/26 | +7.52% since 01/02/26 | ||
| Low | 10.09 on 02/16/24 | 11.01 on 01/05/26 | 12.87 on 01/05/26 | ||
| High | 10.35 on 02/14/24 | 12.74 on 01/06/26 | 15.80 on 01/07/26 | ||
| 1-Month | |||||
| %Chg | +2.60% since 01/19/24 | -7.86% since 12/09/25 | +14.70% since 12/09/25 | ||
| Low | 9.97 on 01/22/24 | 11.01 on 01/05/26 | 12.61 on 12/10/25 | ||
| High | 10.44 on 02/09/24 | 13.36 on 12/10/25 | 15.80 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +109.61% since 11/21/23 | +25.86% since 10/09/25 | +19.88% since 10/09/25 | ||
| Low | 3.80 on 11/28/23 | 8.78 on 10/15/25 | 10.70 on 11/18/25 | ||
| High | 10.44 on 02/09/24 | 14.22 on 11/18/25 | 15.80 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +222.33% since 08/21/23 | +46.66% since 07/09/25 | +59.11% since 07/09/25 | ||
| Low | 2.10 on 10/04/23 | 6.05 on 08/07/25 | 7.35 on 08/11/25 | ||
| High | 10.44 on 02/09/24 | 14.22 on 11/18/25 | 15.80 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 744,950 | 775,184 | 738,590 | ||
| Shares Outstanding, K | 72,678 | 64,224 | 50,623 | ||
| Annual Sales | 0 | 263,400,000 | 83,330,000 | ||
| Annual Net Income | -88,080,000 | -198,900,000 | -227,100,000 | ||
| Last Quarter Sales | 0 | 41,900,000 | 29,730,000 | ||
| Last Quarter Net Income | -9,270,000 | -35,100,000 | -61,940,000 | ||
| 60-Month Beta | -0.33 | 1.89 | 1.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/13/23 | -0.48 on 11/05/25 | -1.20 on 11/06/25 | ||
| Latest Earnings Date | 03/11/24 | 02/10/26 | 03/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||